OMER - Omeros Corp. Operating Profitability

OMER (Omeros Corporation) - company brandmark

Omeros Corporation (OMER) revenues are independent of economic cycles, as demand for specialized medications remains stable. The company's high pricing power is based on unique MASP-2 inhibitors, which is confirmed by the change in operating margin. The value of -56.40 captures the current magnitude of the indicator. However, the lack of stable cash generators makes the business dependent on external investments and patent protection.

Omeros Corp (OMER): Operating Profit Rate from 07/04/2022 to 11/20/2026

Financial and market metric breakdowns for Omeros Corp (OMER)

- price and consensus price forecast:
- market capitalization statistics:
Initial company analysis:OMER, Omeros Corporation
Brand item of Omeros

Operating margin measures the efficiency of the core business by determining the share of profit before interest and taxes relative to total revenue. By analyzing the operating profit margin history, an investor assesses the company's ability to control costs. The metric is calculated as the ratio of operating income to sales. For Omeros Corporation (OMER), strong pricing power in the rare endothelial pathology segment should ensure the stability of this indicator. Inelastic demand for unique MASP-2 inhibitors creates a foundation for margin growth.

Competitors of Omeros Corporation

Operating Sales Margin BIIB|NBIX: Operating Profit Rate|Operating Profitability Regencell Bioscience Ltd (RGC)|Operating Margin axsome.com (AXSM)|Operating Margin ACAD (acadia-pharm.com)|XENE - Operating Sales Margin|vikingtherapeutics.com - Operating Margin|Supernus Pharma (SUPN) - Operating Sales Margin|CPRX: Operating Margin|Denali Therapeutics Inc. (DNLI) - Operating Margin|Operating Profitability Harmony Pharma|Operating Profitability BHVN|Operating Sales Margin AMLX (Amylyx Pharmaceuticals, Inc.)|Operating Sales Margin Trevi Corp TRVI|Operating Profitability praxismedicines.com PRAX|AVXL - Operating Sales Margin|CeriBell EEG - Operating Margin|Operating Return on Sales prothena.com|Alector Therapeutics (ALEC) - Operating Profitability|Annexon Biosciences Inc. - Operating Profit Rate|Operating Sales Margin NGNE|ACIU: Operating Profit Rate|Operating Sales Margin VYGR (Voyager Corp)|Operating Sales Margin Neumora NMRA|Operating Profitability Scilex Holding Company, Inc. SCLX|Operating Profitability Margin Tevogen Bio Inc.|ACOG - Operating Profitability|Operating Profitability Margin Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Operating Sales Margin|Cassava Sciences Inc (SAVA) - Operating Margin|Operating Sales Margin ASRT|Operating Margin coyatherapeutics.com|Operating Margin VTGN|Ovid Therapeutics - Return on Sales by Operating Profit|Operating Margin ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Operating Sales Margin|ATHE - Operating Profitability|Profitability of Operations clene.com CLNN|PEPG: Operating Margin|Return on Sales by Operating Profit JUNS|RLMD (Relmada Corp) - Operating Margin|Annovis Bio Inc (ANVS) - Profitability of Operations|Operating Profitability Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Operating Profit Rate|Operating Profitability Klotho Neurosciences KLTO|NRSN: Return on Sales by Operating Profit|RVPH: Operating Sales Margin|MTVA: Operating Profitability|NRXS (NeurAxis Inc) - Operating Sales Margin|Operating Sales Margin Helius Medical Technologies, Inc.|Operating Profitability Passage Bio Inc.|Operating Return on Sales bionomics.com.au NEUP|Operating Margin NERV|Operating Margin Athira Pharma Inc (ATHA)|Operating Margin ADXN (Addex Therapeutics Ltd.)|ALZN: Return on Sales by Operating Profit|CYCN - Operating Profitability|Operating Return on Sales Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Operating Sales Margin|Operating Profitability Margin Cortigent, Inc. CRGT|Operating Profitability Avenue Therapeutics, Inc.|Operating Sales Margin BrainStorm Cell Therapeutics Inc. (BCLI)|Operating Profitability Cara Therapeutics, Inc (CARA)|Operating Profitability CHRO (Chromocell Therapeutics Corp.)|Operating Margin ELYM (eliemtx.com)|intracellulartherapies.com - Operating Profitability|LBPH: Operating Sales Margin|Operating Profit Rate MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Operating Sales Margin|Operating Sales Margin NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Operating Margin|Neurotrope - Operating Profit Margin|Operating Margin TRVN|Profitability of Operations Vigil Neuroscience, Inc.|Operating Profitability Anew Medical, Inc. WENA|CERE - Operating Sales Margin